Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.61 |
| ▸ | CNR2 | P34972 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.61 |
| ▸ | PPARG | P37231 | 2/20 | 0.59 |
| ▸ | PPARA | Q07869 | 2/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.58 |
| ▸ | P2RY10 | O00398 | 4/20 | 0.56 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.55 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.55 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.55 |
| ▸ | GPR174 | Q9BXC1 | 3/20 | 0.54 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12255204 | 0.95 | CYP2D6 (0.59) | CNR1CNR2CYP2D6PPARGPPARA | |
| Phenyl Propionic Acid SCHEMBL28547712 | 0.93 | PPARA (0.58) | CNR1CNR2CYP2D6PPARGPPARA | |
| SCHEMBL9120700 | 0.90 | POLB (0.50) | CNR1CNR2CYP2D6PPARGPPARA | |
| SCHEMBL28983024 | 0.88 | P2RY10 (0.63) | CNR1CNR2CYP2D6PPARGPPARA | |
| SCHEMBL28589342 | 0.88 | CYP2D6 (0.61) | CNR1CNR2CYP2D6PPARGPPARA | |
| Phenyl Propionic Acid SCHEMBL28554549 | 0.88 | FFAR1 (0.60) | CYP2D6PPARGPPARAKCNH2PLA2G4B | |
| SCHEMBL9119125 | 0.87 | P2RY10 (0.49) | CNR1CNR2CYP2D6PPARGPPARA | |
| SCHEMBL25456542 | 0.86 | PPARA (0.69) | CNR1CNR2CYP2D6PPARGPPARA | |
| SCHEMBL9402581 | 0.86 | PLA2G4B (0.64) | CNR1CNR2CYP2D6PPARGPPARA | |
| SCHEMBL17345292 | 0.86 | PPARA (0.69) | CNR1CNR2CYP2D6PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9469665-B2 | Compound having lysophosphatidylserine receptor function modulation activity | THE UNIVERSITY OF TOKYO (JP) | 2016-10-18 | — | — | US | disclosed |
| US-20150361119-A1 | COMPOUND HAVING LYSOPHOSPHATIDYLSERINE RECEPTOR FUNCTION MODULATION ACTIVITY | TOHOKU UNIVERSITY (JP) | 2015-12-17 | — | — | US | disclosed |
| EP-2952517-A1 | COMPOUND EXHIBITING REGULATORY ACTIVITY ON LYSOPHOSPHATIDYLSERINE RECEPTOR FUNCTION | The University of Tokyo (JP) | 2015-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150361119-A1 | COMPOUND HAVING LYSOPHOSPHATIDYLSERINE RECEPTOR FUNCTION MODULATION ACTIVITY | LPAR1, LPAR3, LPAR2 | CNR1 22/4885CNR2 29/4885CYP2D6 4253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.